Lilly, Hims reach GLP-1 deal; Alnylam sales chief to step down

Coverage, in order

1. 5d ago
   first Pharmaphorum UK indie

   Lilly partners with Hims & Hers on obesity drug sales

   Lilly partners with Hims & Hers on obesity drug sales Phil.Taylor Fri, 06/11/2026 - 13:09

2. 5d ago
   
   BioPharma Dive indie

   Lilly, Hims reach GLP-1 deal; Alnylam sales chief to step down

   The deal is part of a course change for Hims, which had previously sold knockoff GLP-1 drugs. Elsewhere, a medicine Servier recently acquired failed a key trial and Ultragenyx announced staff cuts.

3. 5d ago
   Fierce Healthcare indie

   Hims & Hers inks deal with Eli Lilly to offer branded weight loss drugs

   Hims & Hers struck a deal with Eli Lilly to offer the drugmaker’s branded obesity treatments through its online health and wellness platform.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.